Naomi Judd Adopts Holistic Lifestyle and Overcomes Hepatitis C
Find out when this country singer was diagnosed with Hepatitis C and why she feels meditation saved her life.
Continue reading »
Research & Treatment News
Share
Follow Us
A New Hepatitis C Medicine: Faldaprevir
Learn about the trial results for faldaprevir, a once-daily hepatitis C virus (HCV) NS3/4A protease inhibitor.
Continue reading »
4 Hepatitis C Dietary Myths
Jan 17, 2014
19 Comments
Debunking these four myths about what to consume or avoid with Hepatitis C will help you make better liver health choices.
Continue reading »
For Patients and Caregivers: Free Webinar on Hepatic Encephalopathy
Jan 16, 2014
1 Comment
The American Liver Foundation invites you to participate in the first of a four-part series of live webinars on hepatic encephalopathy (HE) designed for patients and caregivers.
Continue reading »Hep C Drug Pipeline: New Additions and Three Combos to Watch for in 2014
Jan 2, 2014
37 Comments
A handy guide to show which drugs are available now and who the top contenders are for an anticipated 2014, interferon-free, Hepatitis C cure.
Continue reading »
Price of Pill that Will Likely Cure 90% of Hep C Patients
Jan 2, 2014
205 Comments
Learn about estimated costs for the drug sofosbuvir (brand name Sovaldi) that will help treat patients with Hepatitis C. Gregg Alton, a vice president at Gilead, comments that, "Gilead will help U.S. patients pay for sofosbuvir if they can't afford it...or the company will help them look for drug coverage."
Continue reading »
Sovaldi™ (sofosbuvir) and Hepatitis C
Dec 31, 2013
28 Comments
With the approval of Sovaldi™ (sofosbuvir) once a day combination treatment of those with Hepatitis C, genotype 1, 2, 3 and 4, many questions arise. Here we have summarized some of these questions.
Continue reading »
Combining Well Care and Sick Care for Hepatitis C
Dec 30, 2013
2 Comments
Simultaneously using alternative medicine with antiviral therapy gives Hepatitis C sufferers the best possible outcome.
Continue reading »Danoprevir Demonstrated an 85% Sustained Virologic Response Rate
Dec 18, 2013
1 Comment
Learn about the positive results from phase 2 trials of adding danoprevir to the current treatment regimen (peginterferon alfa-2a/ribavirin) for Hepatitis C.
Continue reading »
Fish Oil Eases Hep C Therapy-Related Anemia
Dec 18, 2013
1 Comment
Discover why omega 3-fatty acids may be extremely valuable for preventing hemolytic anemia –one of the most challenging, potential side effects of Hepatitis C combination therapy.
Continue reading »
